2018

Staff Spotlight: Jaume Vidal

Time for a Treaty? ReAct Reports on Second Consultation on Global Development & Stewardship Framework to Combat AMR

Medicijnen: de link met de maatschappij

What Role Can Civil Society Play in the European Regulatory Process?

On the Road in Kilifi County: HAI Launches Snakebite Programme in Kenya

Open Science for Health: Shaping the New Framework Programme

2017

EU-Mercosur Trade Agreement: A bad deal for transparency, policy coherence and access to medicines

The Forgotten Victims of Snakebite

New Dutch Government Must Ensure Transparency to Control Medicine Prices

Staff Spotlight: Tim Reed

Giving Snakebite Victims a Voice

HAI’s Research into Access to Sexual and Reproductive Health Commodities Now in Full Swing

Staff Spotlight: Gemma Buckland-Merrett

Staff Spotlight: Mieke Bakx

Small country, big thinkers: Why it’s only natural for the Netherlands to take on a pioneering role in snakebite advocacy

Staff Spotlight: Molly Lepeska

European Commission Appoints Health Action International to HTA Network Stakeholder Pool

2016

Health Action International Launches Study to Examine Access to Sexual and Reproductive Health Commodities in Kenya, Uganda and Zambia

Clinical Trial Data Transparency on Trial – EMA Under Pressure From Pharma Lawsuit

Next Gen Advocates Excel at HAI/HP4L Summer School on Access to Medicines

Top Experts to Discuss Global Initiatives to Reduce Snakebite Death & Disability at WHA69 Side Event

ACCISS Infographics

Farewell to Access to Medicines Pioneer, Andrew Herxheimer

Insulin Still Unattainable for Many Living with Diabetes Worldwide: ACCISS Study Review in The Lancet D&E

2015

HAI/WHO Pharmaceutical Promotion Manual Still Key to Combating Promotion around the World

HAI Holds Workshops on EU Medicines Policy & Access to Medicines in Eastern Europe

HAI urges MEPs to support key amendments to TTIP resolution

The EU-US Trade Deal Could Leave Europeans Sick

HAI Launches Innovative Global Study to Improve Access to Insulin

2014

More work needed on new EMA conflicts of interest policy